You have not accepted cookies yet

This content is blocked. Please accept marketing cookies. You can do this here.

APR 08, 2019 | News

Delivery of world-class neurology centre at UCL moves another step closer

Pre-construction work for the building of a world-leading neurology centre at UCL has moved a step closer with the appointment of ISG as UCL’s main contractor. The project team is being led by Arcadis, which will provide project management, cost management and specialist support services.

The new centre will serve as a hub for the UK Dementia Research Institute and a new home for the UCL Queen Square Institute of Neurology. It is anticipated that building work will begin early in 2020, with completion scheduled for late 2023 in readiness for a process of migration and occupation in 2024. The site, on Gray’s Inn Road, will bring together hundreds of clinicians and researchers from different disciplines to tackle the global health challenges of neurological diseases.



The new development is part of Transforming UCL, a £1.25 billion ten-year programme of investment in UCL’s estate to support the university’s continuing growth. Along with the new neurology centre in King’s Cross, the programme is seeing the creation of new world-class facilities in UCL’s Bloomsbury campus - where Arcadis was central to the delivery of The Sainsbury Wellcome Centre for Neural Circuits and Behaviour; a purpose-built, state-of-the-art systems neuroscience research facility - and the construction of UCL East, an entirely new campus in east London, adjacent to the Olympic Park. 


Professor Alan Thompson, Dean of the UCL Faculty of Brain Sciences, said:


“The new site will provide a home to three world-leading organisations: the UCL Queen Square Institute of Neurology, the headquarters and UCL component of the UK Dementia Research Institute, and the National Hospital for Neurology and Neurosurgery. 


“Bringing these three powerhouses together under one roof will create the leading translational neurology research centre in the world, delivering innovative new discoveries and translating these into treatments that improve the health of patients suffering with dementia and other neurological diseases. 



“The new site, within minutes of Queen Square, will provide state-of-the-art facilities and enabling technologies, ensuring that our research scientists have the very best chance of discovering new treatments for these devastating diseases.”



The UK Dementia Research Institute, launched in 2016, is headquartered at UCL and brings together world-class academics at six universities across the UK.



Professor Bart De Strooper, UK Dementia Research Institute Director, said:


“The UK Dementia Research Institute has been set up to find scientific solutions to one of society’s biggest health challenges. We have a huge knowledge gap in dementia – our mission at the UK Dementia Research Institute is to fill that gap. I see our UCL hub as part of a virtual UK Dementia Research Institute building.”


The project is being designed to BIM Level 2 standards using fully collaborative web-based software, and is targeting BREEAM Excellent, with an aspiration for Outstanding.



The facilities will create a shared, open and collaborative environment for over 500 neuroscience researchers, including a specialist NHS clinical component led by UCLH. The new site will also incorporate space for public engagement, allowing connection to communities and shared progress in finding better ways to diagnose, treat and prevent dementia.



Mel Manku, Partner and Science & Education Lead at Arcadis, said:


“Many of us will have known someone who has been affected by neurological and specifically dementia related diseases – it is heart-breaking to see individuals and their families trying to cope with what these diseases throw at them. 


“We are extremely privileged and honoured to be leading this project, which will create an environment for collaboration across the spectrum to enable thorough research and translation into therapies for suffering patients, with the hope of developing preventative solutions. 



“This facility is critical to achieving these goals and for UCL and the UK to be the leading voice in this area. The need is so significant that temporary facilities have been created as part of a programme of works, to enable the research to continue in the interim.”



An existing design team, novated to ISG, will be led by the architectural firm Hawkins/Brown and includes the engineering consultancies Hoare Lea and Ramboll.

 



Chris Wiggan

Connect with Chris Wiggan for more information & questions.

Chris Wiggan, Global Corporate Communications Director

Connect with {name} for more information & questions

Arcadis will use your name and email address only to respond to your question. More information can be found in our Privacy policy